CROSS COUNTRY HEALTHCARE INC
CCRNUS売上高
$1.1B
百万USD
営業利益
$-84M
百万USD
純利益
$-95M
百万USD
ROE
-29.4%
最新FY
EPS
$-2.93
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $329M | $19M | $0.53 |
| FY2021 | Q2 | $332M | $12M | $0.31 |
| FY2021 | Q3 | $375M | $23M | $0.62 |
| FY2021 | FY | $1.7B | $132M | $3.53 |
| FY2022 | Q1 | $789M | $62M | $1.63 |
| FY2022 | Q2 | $754M | $53M | $1.40 |
| FY2022 | Q3 | $636M | $35M | $0.93 |
| FY2022 | FY | $2.8B | $188M | $5.02 |
| FY2023 | Q1 | $623M | $29M | $0.81 |
| FY2023 | Q2 | $541M | $21M | $0.60 |
| FY2023 | Q3 | $442M | $13M | $0.36 |
| FY2023 | FY | $2.0B | $73M | $2.05 |
| FY2024 | Q1 | $379M | $3M | $0.08 |
| FY2024 | Q2 | $340M | $-16M | $-0.47 |
| FY2024 | Q3 | $315M | $3M | $0.08 |
| FY2024 | FY | $1.3B | $-15M | $-0.44 |
| FY2025 | Q1 | $293M | $-0M | $-0.02 |
| FY2025 | Q2 | $274M | $-7M | $-0.20 |
| FY2025 | Q3 | $250M | $-5M | $-0.15 |
| FY2025 | FY | $1.1B | $-95M | $-2.93 |
| FY2026 | Q1 | $241M | $-4M | $-0.14 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $816M | $822M | $836M | $1.7B | $2.8B | $2.0B | $1.3B | $1.1B |
| 営業利益 | $6M | $12M | $-13M | $-16M | $-9M | $139M | $273M | $113M | $-17M | $-84M |
| 純利益 | $8M | $38M | $-17M | $-58M | $-13M | $132M | $188M | $73M | $-15M | $-95M |
| 総資産 | $388M | $468M | $427M | $382M | $357M | $733M | $948M | $679M | $589M | $449M |
| 純資産 | $152M | $238M | $218M | $164M | $155M | $298M | $457M | $473M | - | - |
| 自己資本 | $151M | $237M | $218M | $163M | $154M | $298M | $457M | $473M | $419M | $323M |
| 営業CF | $30M | $46M | $21M | $6M | $27M | $-86M | $134M | $248M | $120M | $48M |
| EPS | $0.15 | $1.01 | $-0.48 | $-1.61 | - | $3.53 | $5.02 | $2.05 | $-0.44 | $-2.93 |
| BPS | $4.59 | $6.51 | $6.02 | $4.41 | $4.12 | $7.82 | $12.42 | $13.63 | $12.78 | $9.99 |
| ROE | 5.3% | 15.8% | -7.8% | -35.5% | -8.4% | 44.4% | 41.2% | 15.3% | -3.5% | -29.4% |